These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 2581301)

  • 1. Calcium agonism, a new mechanism for positive inotropy. Hemodynamic effects and mode of action of BAY K 8644.
    Schramm M; Towart R; Kazda S; Thomas G; Franckowiak G
    Adv Myocardiol; 1985; 6():59-70. PubMed ID: 2581301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of calcium channels by novel 1,4-dihydropyridines. A new mechanism for positive inotropics or smooth muscle stimulants.
    Schramm M; Thomas G; Towart R; Franckowiak G
    Arzneimittelforschung; 1983; 33(9):1268-72. PubMed ID: 6196037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular and cardiac effects of a new dihydropyridine derivative, YC-170: a comparison with Bay K 8644.
    Hattori Y; Nakaya H; Tohse N; Kanno M
    J Pharmacol Exp Ther; 1986 Aug; 238(2):670-8. PubMed ID: 2426442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular effects of the calcium-agonistic dihydropyridine BAY K 8644 in conscious dogs.
    Gross R; Kayser M; Schramm M; Taniel R; Thomas G
    Arch Int Pharmacodyn Ther; 1985 Oct; 277(2):203-16. PubMed ID: 2415078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel modulation: ability to inhibit or promote calcium influx resides in the same dihydropyridine molecule.
    Thomas G; Gross R; Schramm M
    J Cardiovasc Pharmacol; 1984; 6(6):1170-6. PubMed ID: 6084776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SR 33557, a novel calcium entry blocker. I. In vitro isolated tissue studies.
    Polster P; Christophe B; Van Damme M; Houlliche A; Chatelain P
    J Pharmacol Exp Ther; 1990 Nov; 255(2):593-9. PubMed ID: 1700816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agonist actions of Bay K 8644, a dihydropyridine derivative, on the voltage-dependent calcium influx in smooth muscle cells of the rabbit mesenteric artery.
    Kanmura Y; Itoh T; Kuriyama H
    J Pharmacol Exp Ther; 1984 Dec; 231(3):717-23. PubMed ID: 6209390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihypertensive and cardiovascular effects of the new dihydropyridine derivative methyl (E)-3-phenyl-2-propen-1-yl-1,4-dihydro-2,6-dimethyl- 4-(3-nitrophenyl)pyridine-3,5-dicarboxylate.
    Yamaura T; Kase N; Kita H; Uematsu T
    Arzneimittelforschung; 1986; 36(1):29-34. PubMed ID: 3754142
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
    Barrús MT; Reviriego J; Marín J
    J Auton Pharmacol; 1996 Jun; 16(3):161-7. PubMed ID: 8884463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Bay k 8644 and nifedipine on isolated dog cerebral, coronary and mesenteric arteries.
    Asano M; Aoki K; Suzuki Y; Matsuda T
    J Pharmacol Exp Ther; 1987 Nov; 243(2):646-56. PubMed ID: 2445956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronotropic, inotropic, and vasodilator actions of diltiazem, nifedipine, and verapamil. A comparative study of physiological responses and membrane receptor activity.
    Millard RW; Grupp G; Grupp IL; DiSalvo J; DePover A; Schwartz A
    Circ Res; 1983 Feb; 52(2 Pt 2):I29-39. PubMed ID: 6831652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of 2-amino-1,4-dihydro-4-(2-[4-[4-(2-methoxyphenyl)-1- piperazinyl]butylsulfinyl]phenyl)-6-methyl-5-nitro-3-pyridine carboxylic acid methyl ester (XB513), a novel calcium agonist with alpha-1 adrenergic receptor antagonistic.
    Wong PC; Aldrich PE; Chiu AT; Earl RA; Hart SD; Johnson AL; Ma P; McCall DE; Price WA; Smith RD
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1088-95. PubMed ID: 8099616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Calcium antagonists: effect on peripheral and coronary hemodynamics].
    Simon R
    Z Kardiol; 1984; 73 Suppl 2():79-88. PubMed ID: 6528705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contractile effects of Bay k 8644, a dihydropyridine calcium agonist, on isolated femoral arteries from spontaneously hypertensive rats.
    Asano M; Aoki K; Matsuda T
    J Pharmacol Exp Ther; 1986 Oct; 239(1):198-205. PubMed ID: 2428972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of dihydropyridine-type calcium agonists on hemodynamics and myocardial ischemia in isolated rabbit hearts.
    Rump AF; Rösen R; Sigmund B; Fuchs J; Ratke R; Klaus W
    Arzneimittelforschung; 1993 Oct; 43(10):1056-9. PubMed ID: 7505584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nitrendipine (BAY e 5009), nifedipine, verapamil, phentolamine, papaverine, and minoxidil on contractions of isolated rabbit aortic smooth muscle.
    Towart R
    J Cardiovasc Pharmacol; 1982; 4(6):895-902. PubMed ID: 6185780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic effects of the new vasodilator drug Bay k 5552 in man.
    Vogt A; Neuhaus KL; Kreuzer H
    Arzneimittelforschung; 1980; 30(12):2162-4. PubMed ID: 7194078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The optical isomers of the 1,4-dihydropyridine BAY K 8644 show opposite effects on Ca channels.
    Franckowiak G; Bechem M; Schramm M; Thomas G
    Eur J Pharmacol; 1985 Aug; 114(2):223-6. PubMed ID: 2412855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation of Ca-dependent action potentials in mammalian ventricular myocardium by a novel dihydropyridine.
    Nilius B
    Biomed Biochim Acta; 1984; 43(12):1385-97. PubMed ID: 6085472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.